Tag: HCPs

Latest articles

Ground-breaking AI test could transform breast cancer diagnosis and treatment

Ground-breaking AI test could transform breast cancer diagnosis and treatment

Panakeia’s PANProfiler Breast assay - the world’s first AI software that can predict biomarker status from digitally imaged routine pathology samples - has received...
NHS Confederation calls for more measures to avoid a winter crisis

NHS Confederation calls for more measures to avoid a winter crisis

The NHS Confederation is calling for a ‘Plan B plus’ in a plea for the government to introduce measures, such as mandatory face coverings...
Star OUTiCO achieves Platinum Investors In People accreditation

Star OUTiCO achieves Platinum Investors In People accreditation

Star OUTiCO, a market-leading provider of outsourced digitally enabled commercial services to the pharmaceutical industry, and part of the global Uniphar Group, has announced...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Adapting for success: Understanding commercial optimisation

Adapting for success: Understanding commercial optimisation

How do you best align your field force with the changing landscape within the NHS? Oli Hudson, Content Director at Wilmington Healthcare, outlines the...
NHS Confederation calls for more measures to avoid a winter crisis

NHS Confederation calls for more measures to avoid a winter crisis

The NHS Confederation is calling for a ‘Plan B plus’ in a plea for the government to introduce measures, such as mandatory face coverings...
NICE recommends Ofev for the treatment of PF-ILD

NICE recommends Ofev for the treatment of PF-ILD

The National Institute for Health and Care Excellence (NICE) has recommended Ofev® (nintedanib) for use in England and Wales for the treatment of adult patients...
Amgen’s Lumykras gains MHRA approval under Project Orbis

Amgen’s Lumykras gains MHRA approval under Project Orbis

Amgen’s first-in-class medicine Lumykras (sotorasib) has become the first new cancer therapy to receive Conditional Marketing Authorisation for use1 across England, Scotland and Wales...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription